Pulse cyclophosphamide decreases sympathetic postganglionic activity, controls alveolitis, and normalizes vascular tone dysfunction (Raynaud's phenomenon) in a case of early systemic sclerosis

Arthritis Rheum. 2004 Aug 15;51(4):665-9. doi: 10.1002/art.20542.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antirheumatic Agents / administration & dosage*
  • Cyclophosphamide / administration & dosage*
  • Female
  • Humans
  • Middle Aged
  • Pulmonary Fibrosis / drug therapy*
  • Pulmonary Fibrosis / etiology
  • Pulse Therapy, Drug
  • Raynaud Disease / drug therapy*
  • Raynaud Disease / etiology
  • Scleroderma, Systemic / complications
  • Scleroderma, Systemic / drug therapy*
  • Sympathetic Nervous System / drug effects

Substances

  • Antirheumatic Agents
  • Cyclophosphamide